Meningococcus, a bacterium belonging to the Neisseria genus, is a significant cause of meningitis and other severe infections worldwide. Neisseria meningitidis, the primary pathogenic species, is responsible for the majority of meningococcal disease cases, which can manifest as meningitis, septicemia, or a combination of both. Meningococcal meningitis, characterized by inflammation of the membranes surrounding the brain and spinal cord, poses a serious public health threat due to its potential for rapid transmission and high mortality rates if left untreated. The bacterium is transmitted through respiratory droplets and can cause outbreaks, particularly in crowded settings such as college dormitories or military barracks. Vaccination against meningococcus, particularly with conjugate vaccines targeting specific serogroups, has been instrumental in reducing the incidence of meningococcal disease, highlighting the importance of preventive measures in controlling this infectious threat.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain